Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Employees

129

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
24/09/26	ILA 4,000.00	-3.61%	66,819
23/09/26	ILA 4,150.00	+2.77%	111,881
22/09/26	ILA 4,038.00	-1.42%	130,885
17/09/26	ILA 4,096.00	+0.24%	18,173

Delayed Quote TEL AVIV STOCK EXCHANGE

More quotes

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - TEL AVIV STOCK EXCHANGE 15:24:13 24/09/2026 BST			5-day change	1st Jan Change
4,000.00 ^ILa	-3.61%		-2.34%	+28.00%

09-21	BrainsWay Ltd.(NasdaqGM:BWAY) dropped from S&P Global BMI Index	CI
09-20	BrainsWay Ltd.(TASE:BWAY) added to S&P Global BMI Index	CI

Market Cap	527M 0 463M 437M 398M 746M 50.55B 751M 5.23B 2.03B 25.82B 1.98B 1.94B 82.99B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	527M 0 463M 437M 398M 746M 50.55B 751M 5.23B 2.03B 25.82B 1.98B 1.94B 82.99B	EV / Sales 2026 *	7.63x	EV / Sales 2027 *	6.18x
Free-Float	90.5%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
TEL AVIV STOCK EXCHANGE	BWAY	Delayed
OTC Markets	BRSYF	Delayed

09-21	BrainsWay Ltd.(NasdaqGM:BWAY) dropped from S&P Global BMI Index	CI
09-20	BrainsWay Ltd.(TASE:BWAY) added to S&P Global BMI Index	CI
09-08	Brainsway Reports Promising Pilot Study Results In Patients With Depression And Comorbid Early-Stage Alzheimer's Disease Treated With Deep TMS	CI
08-31	Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO	MT
08-27	BrainsWay Ltd. Publishes Peer-Reviewed Data Demonstrating 70% Reduction in Suicidal Ideation with Deep TMS in Major Depressive Disorder	CI
08-12	BrainsWay Shares Rise After Higher Q2 Results	MT
08-12	BrainsWay Ltd., Q2 2026 Earnings Call, Aug 12, 2026
08-12	BrainsWay Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-12	BrainsWay Ltd. Raises Earnings Guidance for the Fiscal Year 2026	CI
07-20	Radial Health, S.C. announced that it has received $53 million in funding from a group of investors	CI
07-20	BTIG Initiates Brainsway at Buy With $18 Price Target	MT
07-16	Sound Minds Behavioral announced that it expects to receive $0.5 million in funding from BrainsWay Ltd.	CI
07-16	BrainsWay Announces Strategic Investment in Sound Minds Behavioral	MT

BrainsWay Ltd. Share Price

Stocks

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Valuation: BrainsWay Ltd.

Chart: BrainsWay Ltd.

Latest news: BrainsWay Ltd.

Last Transcript: BrainsWay Ltd.

Analysts' recommendations: BrainsWay Ltd.

Press Releases: BrainsWay Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: BrainsWay Ltd.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

07-20	BTIG Initiates Brainsway at Buy With $18 Price Target	MT
11-13	BrainsWay Ltd. Receives FDA Clearance of Deep TMS as Adjunct Therapy for Major Depressive Disorder in Adolescents Aged 15 to 21	CI
14/05/25	Oppenheimer Adjusts Brainsway Price Target to $15 From $13, Maintains Outperform Rating	MT
09/05/24	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
09/05/24	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT

1 day	-3.61%
1 week	-2.34%
Current month	-10.77%
1 month	-7.86%
3 months	-8.97%
6 months	-8.47%
Current year	+28.00%

1 week	3,899	4,229
1 month	3,899	4,483
Current year	3,080	5,165
1 year	2,391	5,165
3 years	652.1	5,165
5 years	272	5,165
10 years	272	5,165

Manager	Title	Age	Since
Hadar Levy CEO	Chief Executive Officer	54	12/02/2023
Yiftach Roth CTO	Chief Tech/Sci/R&D Officer	56	30/04/2006
Ido Marom DFI	Director of Finance/CFO	50	22/05/2023

Director	Title	Age	Since
David Zacut CHM	Chairman	74	31/12/2002
Avner Hagai BRD	Director/Board Member	70	31/10/2006
Abraham Zangen BRD	Director/Board Member	56	16/06/2019

Date	Insider	Type	Main position	Quantity	% Market Cap.
02/06/26	Yiftach Roth	Sell	Founder	-3,000	0.0075%
26/05/26	Eti Mitrany	Sell	Director	-7,980	0.0399%
20/05/26	Eti Mitrany	Exercice	Director	41,080	0.1026%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRAINSWAY LTD.	-3.61%	-2.34%	+62.34%	+394.56%	528M
THERMO FISHER SCIENTIFIC, INC.	-0.50%	+3.62%	+46.99%	+33.49%	250B
DANAHER CORPORATION	+0.32%	+5.99%	+23.71%	-10.93%	158B
INTUITIVE SURGICAL, INC.	+1.42%	+3.01%	-7.52%	+38.17%	143B
BOSTON SCIENTIFIC CORPORATION	-1.70%	+1.34%	-55.25%	-18.36%	63.65B
EDWARDS LIFESCIENCES CORPORATION	+0.65%	-2.23%	+14.64%	+24.23%	49.74B
AGILENT TECHNOLOGIES, INC.	-0.03%	+10.43%	+41.76%	+54.36%	48.71B
SIEMENS HEALTHINEERS AG	+1.56%	+0.05%	-15.70%	-20.02%	47.94B
WATERS CORPORATION	+0.75%	+2.82%	+50.64%	+60.00%	42.59B
ILLUMINA, INC.	-1.42%	+12.68%	+192.87%	+105.46%	40.77B
Average	-0.26%	+3.57%	+35.45%	+66.10%	84.45B
Weighted average by Cap.	+0.12%	+4.18%	+27.17%	+24.73%

	2026 *	2027 *
Net sales	69.16M 0 60.68M 57.31M 52.23M 97.77M 6.63B 98.47M 686M 266M 3.39B 260M 254M 10.88B	85.34M 0 74.88M 70.72M 64.45M 121M 8.18B 122M 846M 328M 4.18B 320M 313M 13.43B
Net income	12.38M 0 10.87M 10.26M 9.35M 17.51M 1.19B 17.63M 123M 47.57M 606M 46.5M 45.49M 1.95B	20.96M 0 18.4M 17.37M 15.83M 29.64M 2.01B 29.85M 208M 80.53M 1.03B 78.71M 77.01M 3.3B
Net Debt	-	-